ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years
Jinyuan Song
Matched on ORCID iD 0000-0003-2609-2030; OpenAlex author ID A5112898456. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Corrigendum to Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci211838↗
- Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci187024↗
- Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation. First author DOI 10.1016/j.celrep.2023.112620↗
- Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations using flow cytometry. Co-author DOI 10.1016/j.xpro.2023.102679↗
- Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. Co-author DOI 10.1186/s13046-022-02273-w↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tingbo Liang · 4 shared papers, 2022–2025 · strength 0.69
- Paper Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations us… DOI 10.1016/j.xpro.2023.102679↗
- Paper Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ducta… DOI 10.1172/jci187024↗
- Paper Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. DOI 10.1186/s13046-022-02273-w↗
- Xueli Bai · 4 shared papers, 2022–2025 · strength 0.69
- Paper Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations us… DOI 10.1016/j.xpro.2023.102679↗
- Paper Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ducta… DOI 10.1172/jci187024↗
- Paper Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. DOI 10.1186/s13046-022-02273-w↗
- Xiao Zhi · 2 shared papers, 2025–2026 · strength 0.37
- Mao Ye · 2 shared papers, 2025–2026 · strength 0.37
- Xiongbin Lu · 2 shared papers, 2025–2026 · strength 0.37
- Kang Sun · 2 shared papers, 2025–2026 · strength 0.37
- Mengyi Lao · 2 shared papers, 2025–2026 · strength 0.37
- Lingyue Liu · 2 shared papers, 2022–2025 · strength 0.33
- Tingbo Liang · 1 shared paper, 2026 · strength 0.20
- Hanshen Yang · 1 shared paper, 2025 · strength 0.17
- Xiang Li Ma · 1 shared paper, 2025 · strength 0.17
- Lihong He · 1 shared paper, 2025 · strength 0.17
- Xing Huang · 1 shared paper, 2022 · strength 0.16
- Jiaqi Yang · 1 shared paper, 2022 · strength 0.16
- Junlei Zhang · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.